Protective efficacy of PLGA microspheres loaded with divalent DNA vaccine encoding the ompA gene of Aeromonas veronii and the hly gene of Aeromonas hydrophila in mice

Vaccine

Volumn 31, Issue 48, 2013, Pages 5754-5759

  Gao, Shanshan ^a,b   Zhao, Na ^a,b   Amer, Said ^b,c   Qian, Mingming ^a   Lv, Mengxi ^a   Zhao, Yuliang ^a   Su, Xin ^a   Cao, Jieying ^a   He, Hongxuan ^b   Zhao, Baohua ^a  

^a HEBEI NORMAL UNIVERSITY   (China)

^b INSTITUTE OF ZOOLOGY   (China)

^c Kafrelsheikh University   (Egypt)

Author keywords

Divalent DNA vaccine; Hly gene; OmpA gene; PLGA microspheres

Indexed keywords

DNA VACCINE; HEMOLYSIN; IMMUNOGLOBULIN G; MICROSPHERE; OUTER MEMBRANE PROTEIN A; POLYGLACTIN; RECOMBINANT PET 28A OMPA HLY; RECOMBINANT PROTEIN; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG;

AEROMONAS HYDROPHILA; AEROMONAS VERONII; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DNA VECTOR; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE INSERTION; GENETIC ANALYSIS; HUMORAL IMMUNITY; IN VITRO STUDY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; WESTERN BLOTTING;

DIVALENT DNA VACCINE; HLY GENE; OMPA GENE; PLGA MICROSPHERES;

AEROMONAS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; DRUG CARRIERS; FEMALE; HEMOLYSIN PROTEINS; IMMUNOGLOBULIN G; LACTIC ACID; MICE; MICE, INBRED BALB C; MICROSPHERES; POLYGLYCOLIC ACID; TIME FACTORS; VACCINATION; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 84886954131     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.053     Document Type: Article

References (49)

1. Janda J.M., Abbott S.L. Evolving concepts regarding the genus Aeromonas: an expanding panorama of species, disease presentations, and unanswered questions. Clin Infect Dis 1998, 27(2):332-344.
2. Isonhood J.H., Drake M. Aeromonas species in foods. J Food Prot 2002, 65(3):575-582.
3. Hofer E., Reis C.M., Theophilo G.N., Cavalcanti V.O., Lima N.V., Henriques Mde.F. Aeromonas associated with an acute diarrhea outbreak in Sao Bento do Una, Pernambuco. Rev Soc Bras Med Trop 2006, 39(2):217-220.
4. Parker J.L., Shaw J.G. Aeromonas spp. clinical microbiology and disease. J Infect 2011, 62(2):109-118.
5. Martino M.E., Fasolato L., Montemurro F., Novelli E., Cardazzo B. Aeromonas spp.: ubiquitous or specialized bugs?. Environ Microbiol 2013, [in press].
6. Chao C.M., Lai C.C., Tang H.J., Ko W.C., Hsueh P.R. Skin and soft-tissue infections caused by Aeromonas species. Eur J Clin Microbiol Infect Dis 2013, 32(4):543-547.
7. Chao C.M., Lai C.C., Tsai H.Y., Wu C.J., Tang H.J., Ko W.C., et al. Pneumonia caused by Aeromonas species in Taiwan, 2004-2011. Eur J Clin Microbiol Infect Dis 2013, 32(8):1069-1075.
8. Janda J.M., Abbott S.L. The genus Aeromonas: taxonomy, pathogenicity and infection. Clin Microbiol Rev 2010, 23(1):35-73.
9. Zhang Q., Shi G.Q., Tang G.P., Zou Z.T., Yao G.H., Zeng G. A foodborne outbreak of Aeromonas hydrophila in a college, Xingyi City, Guizhou, China, 2012. Western Pac Surveill Response J 2012, 3(4):39-43.
10. Zhou Z., Guo D. Catheter-related bacteremia caused by Aeromonas hydrophila in a hemodialysis patient. Infect Control Hosp Epidemiol 2013, 34(7):765-766.
11. Papadakis V., Poniros N., Katsibardi K., Charissiadou A.E., Anastasopoulos J., Polychronopoulou S. Fulminant Aeromonas hydrophila infection during acute lymphoblastic leukemia treatment. J Microbiol Immunol Infect 2012, 45(2):154-157.
12. Chao C.M., Lai C.C., Gau S.J., Hsueh P.R. Skin and soft tissue infection caused by Aeromonas species in cancer patients. J Microbiol Immunol Infect 2013, 46(2):144-146.
13. Ko W.C., Yu K.W., Liu C.Y., Huang C.T., Leu H.S., Chuang Y.C. Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan. Antimicrob Agents Chemother 1996, 40(5):1260-1262.
14. Surek M., Vizzotto B.S., Souza E.M., Pedrosa Fde O., Dallagassa C.B., Farah S.M., et al. Identification and antimicrobial susceptibility of Aeromonas spp. isolated from stool samples of Brazilian subjects with diarrhoea and healthy controls. J Med Microbiol 2010, 59(pt 3):373-374.
15. Qing Y., Chen M., Zhao J., Hu H., Xu H., Ling N., et al. Construction of an HBV DNA vaccine by fusion of the GM-CSF gene to the HBV-S gene and examination of its immune effects in normal and HBV-transgenic mice. Vaccine 2010, 28(26):4301-4307.
16. Kulp D.W., Schief W.R. Advances in structure-based vaccine design. Curr Opin Virol 2013, 3(3):322-331.
17. Sugawara N., Tomita T., Kamio Y. Assembly of Staphylococcus aureus gamma-hemolysin into a pore-forming ring-shaped complex on the surface of human erythrocytes. FEBS Lett. 1997, 410(2-3):333-337.
18. Kozaki S., Asao T., Kamata Y., Sakaguchi G. Characterization of Aeromonas sobria hemolysin by use of monoclonal antibodies against Aeromonas hydrophila hemolysins. J Clin Microbiol 1989, 27(8):1782-1786.
19. Pore D., Chakrabarti M.K. Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate. Vaccine 2013, 31(36):3644-3650.
20. Guan R., Xiong J., Huang W., Guo S. Enhancement of protective immunity in European eel (Anguilla anguilla) against Aeromonas hydrophila and Aeromonas sobria by a recombinant Aeromonas outer membrane protein. Acta Biochim Biophys Sin (Shanghai) 2011, 43(1):79-88.
21. Wang N., Yang Z., Zang M., Liu Y., Lu C. Identification of Omp38 by immunoproteomic analysis and evaluation as a potential vaccine antigen against Aeromonas hydrophila in Chinese breams. Fish Shellfish Immunol 2013, 34(1):74-81.
22. Zhang X.H., Meaden P.G., Austin B. Duplication of hemolysin genes in a virulent isolate of Vibrio harveyi. Appl Environ Microbiol 2001, 67(7):3161-3167.
23. Higa N., Toma C., Koizumi Y., Nakasone N., Nohara T., Masumoto J., et al. Vibrio parahaemolyticus effector proteins suppress inflammasome activation by interfering with host autophagy signaling. PLoS Pathog 2013, 9(1):e1003142.
24. Yang Z., Pan H., Sun H. The immune response and protective efficacy of oral alginate microparticle Aeromonas sobria vaccine in soft-shelled turtles (Trionyx sinensis). Vet Immunol Immunopathol 2007, 119(3-4):299-302.
25. Sharma S., Hinds L.A. Formulation and delivery of vaccines: ongoing challenges for animal management. J Pharm Bioallied Sci 2012, 4(4):258-266.
26. Ohagan D.T., Rahman D., McGee J.P., Jeffery H., Davies M.C., Williams P., et al. Biodegradable microparticles as controlled release antigen delivery systems. Immunology 1991, 73(2):239-242.
27. Jiang G., Woo B.H., Kang F.R., Singh J., DeLuca P.P. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly (d,l-lactide-co-glycolide) microspheres. J Control Rel 2002, 79(1-3):137-145.
28. Corrigan O.I., Li X. Quantifying drug release from PLGA nanoparticulates. Eur J Pharm Sci 2009, 37(3-4):477-485.
29. Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc Chem Res 2000, 33(2):94-101.
30. Behera T., Swain P. Alginate-chitosan-PLGA composite microspheres induce both innate and adaptive immune response through parenteral immunization in fish. Fish Shellfish Immunol 2013, pii: S1050-4648(13)00607-4 (in press).
31. Leleux J., Roy K. Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective. Adv Healthc Mater 2013, 2(1):72-94.
32. Silva J.M., Videira M., Gaspar R., Préat V., Florindo H.F. Immune system targeting by biodegradable nanoparticles for cancer vaccines. J Control Rel 2013, 168(2):179-199.
33. Perez C., De Jesus P., Griebenow K. Preservation of lysozyme structure and function upon encapsulation and release from poly(lactic-co-glycolic) acid microspheres prepared by the water-in-oil-in-water method. Int J Pharm 2002, 248(1-2):193-206.
34. 2 interface: enzyme unfolding and aggregation and its prevention by polyols. J Pharm Pharmacol 2001, 53(September (9)):1217-1226.
35. 2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres. J Control Rel 2003, 89(1):71-85.
36. Alban L., Dahl P.J., Hansen A.K., Hejgaard K.C., Jensen A.L., Kragh M., et al. The welfare impact of increased gavaging doses in rats. Anim Welfare 2001, 10(3):303-314.
37. Castellanos I.J., Cruz G., Crespo R., Griebenow K. Encapsulation-induced aggregation and loss in activity of gamma-chymotrypsin and their prevention. J Control Rel 2002, 81(3):307-319.
38. Khushiramani R.M., Maiti B., Shekar M., Girisha S.K., Akash N., Deepanjali A., et al. Recombinant Aeromonas hydrophila outer membrane protein 48 (Omp48) induces a protective immune response against Aeromonas hydrophila and Edwardsiella tarda. Res Microbiol 2012, 163(4):286-291.
39. Maiti B., Shetty M., Shekar M., Karunasagar I., Karunasagar I. Evaluation of two outer membrane proteins, Aha1 and OmpW of Aeromonas hydrophila as vaccine candidate for common carp. Vet Immunol Immunopathol 2012, 149(3-4):298-301.
40. Scott C.J., Austin B., Austin D.A., Morris P.C. Non-adjuvanted flagellin elicits a non-specific protective immune response in rainbow trout (Oncorhynchus mykiss, Walbaum) towards bacterial infections. Vaccine 2013, 31(32):3262-3267.
41. Wu L., Jiang Y.N., Tang Q., Lin H.X., Lu C.P., Yao H.C. Development of an Aeromonas hydrophila recombinant extracellular protease vaccine. Microb Pathog 2012, 53(5-6):183-188.
42. Thanga Viji V., Deepa K., Velmurugan S., Donio M.B., Adlin Jenifer J., Babu M.M., et al. Vaccination strategies to protect goldfish Carassius auratus against Aeromonas hydrophila infection. Dis Aquat Organ 2013, 104(1):45-57.
43. Ortiz L., Demick K.P., Petersen J.W., Polka M., Rudersdorf R.A., Van der Pol, et al. Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans. J Immunol 1996, 157(10):4554-4567.
44. Chalifour A., Jeannin P., Gauchat J.F., Blaecke A., Malissard M., N'Guyen T., et al. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alphadefensin production. Blood 2004, 104(6):1778-1783.
45. Sun H., Pan H., Yang Z., Shi M. The immune response and protective efficacy of vaccination with oral microparticle Aeromonas sobria vaccine in mice. Int Immunopharmacol 2007, 7(9):1259-1264.
46. Sinyakov M.S., Dror M., Lublin-Tennenbaum T., Salzberg S., Margel S., Avtalion R.R. Nano- and microparticles as adjuvants in vaccine design: success and failure is related to host natural antibodies. Vaccine 2006, 24(42-43):6534-6541.
47. Mittal S.K., Aggarwal N., Sailaja G., van Olphen A., HogenEsch H., North A., et al. Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response. Vaccine 2000, 19(2-3):253-263.
48. Chen S.C., Jones D.H., Fynan E.F., Farrar G.H., Clegg J.C.S., Greenberg H.B., et al. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol 1998, 72(7):5757-5761.
49. Bowersock T.L., Hogenesch H. Oral immunization using microparticles. Controlled drug delivery challenges and strategies 1997, 269-288. American Chemical Society, Washington. K. Park (Ed.).